Alexander Hardy - 01 Dec 2025 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: Chief Executive Officer, Director
Signature: /s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol: BMRN
Transactions as of: 01 Dec 2025
Net transactions value: -$891,546
Form type: 4
Filing time: 02 Dec 2025, 18:29:07 UTC
Previous filing: 18 Mar 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hardy Alexander	Chief Executive Officer, Director	C/O BIOMARIN PHARMACEUTICAL INC, 770 LINDARO STREET, SAN RAFAEL	/s/ Tae Sang Yoo, Attorney-in-Fact	02 Dec 2025	0002001910

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Award	$20,301	+375	+0.21%	$54.14	175,958	30 Apr 2025	Direct	F1
transaction	BMRN	Common Stock	Tax liability	$911,847	-16,570	-9.4%	$55.03	159,388	01 Dec 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan.